re: Ann: Prana accelerates PBT2 commercial de...
Dont take too much notice of the British press. Bapi has never reversed Alzheimers and it is an infusion, not a jab. They took it into a phase3 after failing in phase2. They were able to mine the result to find a sub group of APOE patients who showed some results and have based the phase 3 on that sub group. The trial was completed in 2010, but they decided to continue the trial till 2012 to collect biomarkers. No results were given. They could have had a $10B drug on market now on good results but delayed it two years on secret results. Draw you own conclusions. The partners are PFE,JNJ and ELN.
There was some dodgey ELN market action when that article was released. Maybe it was a bear raid on ELN to harvest stop losses by someone who had advance notice of the article. http://finance.yahoo.com/echarts?s=ELN+Interactive#chart1:symbol=eln;range=5d;indicator=volume+rsi+stochasticslow;charttype=line;crosshair=on;ohlcvalues=0;logscale=off;source=undefined
PBT Price at posting:
23.5¢ Sentiment: ST Buy Disclosure: Held
